[PDF][PDF] Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular …
R Marcus, K Imrie, P Solal-Celigny… - Journal of Clinical …, 2008 - researchgate.net
Journal of Clinical Oncology, 2008•researchgate.net
Purpose To compare the long-term outcome of patients with previously untreated follicular
lymphoma (FL) needing therapy, after treatment with cyclophosphamide, vincristine and
prednisone (CVP) versus CVP plus rituximab (R-CVP) and to evaluate the predictive value
of known prognostic factors after treatment with R-CVP.
lymphoma (FL) needing therapy, after treatment with cyclophosphamide, vincristine and
prednisone (CVP) versus CVP plus rituximab (R-CVP) and to evaluate the predictive value
of known prognostic factors after treatment with R-CVP.
Purpose
To compare the long-term outcome of patients with previously untreated follicular lymphoma (FL) needing therapy, after treatment with cyclophosphamide, vincristine and prednisone (CVP) versus CVP plus rituximab (R-CVP) and to evaluate the predictive value of known prognostic factors after treatment with R-CVP.
researchgate.net